We are live on
!
Find out more
CD
Chapin Davis Portfolio holdings
AUM
$520M
Turnover
15.11%
1-Year Est. Return
117.57%
This Fund
S&P 500
This Quarter
Est. Return
+10.58%
1 Year Est. Return
+117.57%
3 Year Est. Return
+339.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$193M
AUM Growth
+$21.1M
(+12%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
5.68%
Top 10 Holdings %
Top 10 Hldgs %
30.8%
Holding
248
New
45
Increased
110
Reduced
48
Closed
20
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.68M |
| 2 |
Las Vegas Sands
LVS
|
+$2.63M |
| 3 |
Steel Dynamics
STLD
|
+$2.55M |
| 4 |
Wynn Resorts
WYNN
|
+$2.53M |
| 5 |
United Rentals
URI
|
+$2.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$2.85M |
| 2 |
SLB Ltd
SLB
|
+$2.7M |
| 3 |
Eli Lilly
LLY
|
+$2.57M |
| 4 |
AutoZone
AZO
|
+$2.54M |
| 5 |
ConocoPhillips
COP
|
+$2.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.84% |
| 2 | Technology | 20.95% |
| 3 | Consumer Discretionary | 9.31% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
FGI Industries Warrant
FGIWW
$113K
| $9.8K | 0.01% |
28,000
| – | – |
2022 Q4
1 quarter
|
|
|
227
PUT
NVIDIA
NVDA
$5.17T
| $8.03K | ﹤0.01% |
+5,000
| New | +$108K |
2023 Q1
0 quarters
|
|
228
CALL
Coeur Mining
CDE
$15.9B
| $5.3K | ﹤0.01% |
+2,500
| New | +$8.68K |
2023 Q1
0 quarters
|
|
229
AES
AES
$10.7B
| – | – |
-66,936
| Closed | -$1.93M | – |
|
|
230
AutoZone
AZO
$50.5B
| – | – |
-1,030
| Closed | -$2.54M | – |
|
231
Cigna
CI
$79.9B
| – | – |
-620
| Closed | -$205K | – |
|
232
CALL
Walt Disney
DIS
$191B
| – | – |
-1,000
| Closed | -$180 | – |
|
233
Humana
HUM
$49.6B
| – | – |
-1,391
| Closed | -$712K | – |
|
|
234
McKesson
MCK
$117B
| – | – |
-7,599
| Closed | -$2.85M | – |
|
235
Norfolk Southern
NSC
$73.4B
| – | – |
-840
| Closed | -$207K | – |
|
236
Ovintiv
OVV
$19.2B
| – | – |
-5,367
| Closed | -$272K | – |
|
237
CALL
DELISTED
Paramount Global Class B
PARA
| – | – |
-2,500
| Closed | -$3.18K | – |
|
238
Pembina Pipeline
PBA
$29.1B
| – | – |
-6,000
| Closed | -$204K | – |
|
239
Quanta Services
PWR
$95B
| – | – |
-4,708
| Closed | -$671K | – |
|
|
240
SLB Ltd
SLB
$73.5B
| – | – |
-50,457
| Closed | -$2.7M | – |
|
241
SM Energy
SM
$9.4B
| – | – |
-6,345
| Closed | -$221K | – |
|
242
Suncor Energy
SU
$91.3B
| – | – |
-7,889
| Closed | -$250K | – |
|
243
TJX Companies
TJX
$162B
| – | – |
-2,614
| Closed | -$208K | – |
|
244
Targa Resources
TRGP
$63.2B
| – | – |
-4,400
| Closed | -$323K | – |
|
245
Tetra Tech
TTEK
$8.89B
| – | – |
-14,875
| Closed | -$432K | – |
|
246
UBS Group
UBS
$146B
| – | – |
-20,000
| Closed | -$373K | – |
|
247
United Therapeutics
UTHR
$22.9B
| – | – |
-6,716
| Closed | -$1.87M | – |
|
|
MMP
248
DELISTED
Magellan Midstream Partners, L.P.
MMP
| – | – |
-8,159
| Closed | -$410K | – |
|
Similar funds
AIS
SWM
CFA
VP
CFG
MWM
LCWP
WS
Chapin Davis's Q1 2023 Portfolio in Review
As of Q1 2023, Chapin Davis held 248 positions worth $193M, up 12% from $172M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Chapin Davis deployed $11M of net new capital in Q1 2023, opening 45 new positions and adding to 110 existing holdings. Its largest new stake was Las Vegas Sands: 46,919 shares worth $2.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $2.57M trimmed.
- Chapin Davis's largest Q1 2023 buy was Las Vegas Sands: 46,919 shares worth $2.7M.
- Chapin Davis added most to NVIDIA in Q1 2023, an estimated $2.68M increase.
- Chapin Davis's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $2.57M.
- Chapin Davis fully exited McKesson in Q1 2023, selling an estimated $2.85M.
- Chapin Davis's ten largest holdings make up 31% of its $193M portfolio in Q1 2023.
- Chapin Davis opened 45 new positions and closed 20 in Q1 2023.
- Chapin Davis's portfolio value rose 12% quarter-over-quarter to $193M.
Based on Chapin Davis's 13F filing for Q1 2023, filed 13 Apr 2023.